This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Signify Health Future Growth
Future criteria checks 2/6
Key information
11.8%
Earnings growth rate
12.7%
EPS growth rate
| Healthcare earnings growth | 16.3% |
| Revenue growth rate | 18.0% |
| Future return on equity | 13.4% |
| Analyst coverage | Low |
| Last updated | 29 Mar 2023 |
Recent future growth updates
Recent updates
CVS Health to offer bonds to finance purchase of Signify Health
Feb 13Signify Health and Prospect Medical come together to deliver coordinated, high-quality care
Jan 11Checking Signify Health Before The CVS Transaction
Dec 21Signify expands diagnostic offering with spirometry test for lung disease
Oct 18Signify Health jumps on report CVS in talks to acquire for about $8 billion
Sep 02Signify Health: Cathie Wood Now Selling
Aug 15CVS Health seeking purchase of Signify Health - WSJ
Aug 07Signify Health: ECS Wind Down Sheds Light On Compelling Valuation
Jul 21Signify Health Aims Higher With New CMS Terms
Mar 16Revisiting Signify Health
Jan 09Signify Health names Susan Yun as chief people officer
Jun 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 1,159 | 97 | 217 | 252 | 5 |
| 12/31/2023 | 982 | 96 | 217 | 206 | 3 |
| 12/31/2022 | 806 | 77 | 4 | 32 | N/A |
| 9/30/2022 | 784 | -518 | -3 | 30 | N/A |
| 6/30/2022 | 843 | -338 | -5 | 28 | N/A |
| 3/31/2022 | 810 | 32 | -20 | 11 | N/A |
| 12/31/2021 | 653 | 43 | 108 | 130 | N/A |
| 9/30/2021 | 786 | -3 | 100 | 126 | N/A |
| 6/30/2021 | 741 | -23 | 129 | 156 | N/A |
| 3/31/2021 | 659 | -23 | 97 | 126 | N/A |
| 12/31/2020 | 451 | -25 | 16 | 44 | N/A |
| 9/30/2020 | 550 | -8 | -11 | 26 | N/A |
| 12/31/2019 | 502 | N/A | 16 | 42 | N/A |
| 12/31/2018 | 338 | -29 | 23 | 36 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SGFY's forecast earnings growth (11.8% per year) is above the savings rate (2.1%).
Earnings vs Market: SGFY's earnings (11.8% per year) are forecast to grow slower than the US market (15.4% per year).
High Growth Earnings: SGFY's earnings are forecast to grow, but not significantly.
Revenue vs Market: SGFY's revenue (18% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: SGFY's revenue (18% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SGFY's Return on Equity is forecast to be low in 3 years time (13.4%).